Table 1 Clinical characteristics of PV and ET patients

From: CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles

  

JAK2V617F

CALR-mutated

 

PV

ET

ET

No.

26

17

7

Sex (male/female)

10/16 (38%/62%)

5/12 (29%/71%)

6/1 (86%/14%)

Age at onset, years, median (range)

57 (40–77)

61 (37–72)

37 (26–72)

Hemoglobin, g/dL, median (range)

18.4 (14.3–25.1)

14.6 (11.9–18.1)

13.7 (10.6–16.2)

PLT count, X109/L, median (range)

460 (210–902)

677 (481–1168)

979 (632–1400)

WBC count, X109/L, median (range)

9.7 (6.1–89.7)

8.7 (5.9–18.2)

8.1 (5.1–10.4)

Thrombosis at diagnosis, no. (%)

7 (27)

3 (18)

0 (0)